With major PBMs making formulary changes to GLP-1 coverage in 2026, the coverage status of specific medications is actively shifting
Research suggests organic selenium supplementation benefited people with mercury exposure
Support for this idea comes from the observation that tobacco overexpressing both -ECS and GSH-S had an ameliorated phenotype compared to tobacco expressing the first enzyme alone (Creissen et al., 1999)
Existing Health Conditions: Type 2 Diabetes: Both work well
Conflicting Evidence: A major study published in 2024 used registry data for over 2 million children in Sweden and compared siblings (who share genetics and environment)
Recent agreements between the federal government and leading pharmaceutical manufacturers, Novo Nordisk (maker of Ozempic, Wegovy) and Eli Lilly (maker of Mounjaro, Zepbound), will significantly reduce the cost of these drugs for Medicare and Medicaid patients, as well as for those paying out of pocket